Accolade, Inc. (ACCD) |
| 7.02 0 (0%) 04-08 16:00 |
| Open: | 7.02 |
| High: | 7.02 |
| Low: | 7.02 |
| Volume: | 4,543,947 |
| Market Cap: | 576(M) |
| PE Ratio: | -3.08 |
| Exchange: | NASDAQ Global Select |
| Industry: | Medical - Healthcare Information Services |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 7.68 |
| Resistance 1: | 6.50 |
| Pivot price: | 5.27 |
| Support 1: | 4.59 |
| Support 2: | 3.82 |
| 52w High: | 9.67 |
| 52w Low: | 3.08 |
Accolade, Inc., along with its subsidiaries, specializes in providing innovative, technology-driven solutions across the United States. These solutions are designed to empower individuals to better understand, navigate, and ultimately leverage both the complex healthcare system and their available workplace benefits. At the core of its offering is a robust cloud-based platform that delivers comprehensive, multimodal support. This assistance comes from a dedicated team of health assistants and clinical professionals, including registered nurses, physician medical directors, and specialists in behavioral health. Furthermore, Accolade extends its services to include valuable second opinion consultations and crucial decision-making support for healthcare matters. The company primarily serves employers who aim to furnish their employees and their families with a unified, easily accessible resource for all their health, medical care, and benefits-related inquiries. Established in 2007, Accolade, Inc. maintains its corporate headquarters in Plymouth Meeting, Pennsylvania.
| EPS | -2.580 |
| Book Value | 3.410 |
| PEG Ratio | 0.00 |
| Gross Profit | 2.219 |
| Profit Margin (%) | -24.29 |
| Operating Margin (%) | -10.19 |
| Return on Assets (ttm) | -4.7 |
| Return on Equity (ttm) | -44.1 |
Tue, 08 Apr 2025
Accolade completes merger with Transcarent, shifts control - Investing.com
Tue, 04 Feb 2025
Accolade Expands Virtual Care to Medicare Beneficiaries Nationwide Through PlushCare Direct-to-Consumer Offering - Yahoo Finance
Fri, 10 Jan 2025
Accolade, Inc. SEC 10-Q Report - TradingView
Wed, 08 Jan 2025
Seattle health care company to go private in $621 million acquisition deal - The Business Journals
Fri, 03 Mar 2023
Accolade plans to reduce headcount, downsize office footprint - The Business Journals
Mon, 02 May 2022
Accolade stock suffers record plunge after earnings miss, loss of largest customer - MarketWatch
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |